BackgroundThe HIV cascade is an important framework for assessing systems of care, but population-based assessment is lacking for most jurisdictions worldwide. We measured cascade indicators over time in a population-based cohort of diagnosed people living with HIV (PLWH) in Ontario, Canada.MethodsWe created a retrospective cohort of diagnosed PLWH using a centralized laboratory database with HIV diagnostic and viral load (VL) test records linked at the individual-level. Individuals enter the cohort with record of a nominal HIV-positive diagnostic test or VL test, and remain unless administratively lost to follow-up (LTFU, >2 consecutive years with no VL test and no VL test in later years). We calculated the annual percent of diagnosed PLWH...
Introduction In 2010, the Canadian province of British Columbia (BC) initiated the ...
BackgroundRetention in care (RIC) leads to reduced HIV transmission and mortality. Few studies have ...
Introduction Despite the availability of pre-exposure prophylaxis (PrEP) and antiretroviral therapy ...
BackgroundThe HIV cascade is an important framework for assessing systems of care, but population-ba...
Background: Population-based estimates of HIV prevalence, rates of new HIV diagnoses, and mortality ...
The HIV cascade of care (cascade) is a comprehensive tool which identifies attrition along the HIV c...
We aimed to characterize changes in patterns of new HIV diagnoses, HIV-related mortality, and HAART ...
Introduction: The HIV care cascade is increasingly used to evaluate HIV treatment programs at the po...
INTRODUCTION: The HIV care cascade is increasingly used to evaluate HIV treatment programs at the po...
BACKGROUND:We aimed to characterize changes in patterns of new HIV diagnoses, HIV-related mortality,...
BackgroundTo assess the possible impact of antiretroviral therapy improvements, aging, and comorbidi...
The HIV care cascade is increasingly used to evaluate HIV treatment programs at the population level...
ABSTRACT Objective The HIV cascade of care describes the spectrum of engagement in HIV care from di...
Purpose The Comparative Outcomes And Service Utilization Trends (COAST) Study in British Columbia (B...
Background:San Francisco has launched interventions to reduce new human immunodeficiency virus (HIV)...
Introduction In 2010, the Canadian province of British Columbia (BC) initiated the ...
BackgroundRetention in care (RIC) leads to reduced HIV transmission and mortality. Few studies have ...
Introduction Despite the availability of pre-exposure prophylaxis (PrEP) and antiretroviral therapy ...
BackgroundThe HIV cascade is an important framework for assessing systems of care, but population-ba...
Background: Population-based estimates of HIV prevalence, rates of new HIV diagnoses, and mortality ...
The HIV cascade of care (cascade) is a comprehensive tool which identifies attrition along the HIV c...
We aimed to characterize changes in patterns of new HIV diagnoses, HIV-related mortality, and HAART ...
Introduction: The HIV care cascade is increasingly used to evaluate HIV treatment programs at the po...
INTRODUCTION: The HIV care cascade is increasingly used to evaluate HIV treatment programs at the po...
BACKGROUND:We aimed to characterize changes in patterns of new HIV diagnoses, HIV-related mortality,...
BackgroundTo assess the possible impact of antiretroviral therapy improvements, aging, and comorbidi...
The HIV care cascade is increasingly used to evaluate HIV treatment programs at the population level...
ABSTRACT Objective The HIV cascade of care describes the spectrum of engagement in HIV care from di...
Purpose The Comparative Outcomes And Service Utilization Trends (COAST) Study in British Columbia (B...
Background:San Francisco has launched interventions to reduce new human immunodeficiency virus (HIV)...
Introduction In 2010, the Canadian province of British Columbia (BC) initiated the ...
BackgroundRetention in care (RIC) leads to reduced HIV transmission and mortality. Few studies have ...
Introduction Despite the availability of pre-exposure prophylaxis (PrEP) and antiretroviral therapy ...